Home

Backup Konsultieren Aktualisierung low dose tamoxifen studies Samstag Reform Motivieren

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local  and Contralateral Recurrence in Breast Intraepithelial Neoplasia | Journal  of Clinical Oncology
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia | Journal of Clinical Oncology

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy  in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during  Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double  Blinded Phase IIb Trial -
Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial -

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer  recurrence in a low-dose trial | npj Breast Cancer
Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial | npj Breast Cancer

Effect of low-dose tamoxifen after surgical excision of ductal  intraepithelial neoplasia: results of a large retrospective  monoinstitutional cohort study - Annals of Oncology
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study - Annals of Oncology

Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox -  Yu - 2021 - Cancer Communications - Wiley Online Library
Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox - Yu - 2021 - Cancer Communications - Wiley Online Library

Many Women With Breast Cancer Don't Need High Dose Tamoxifen | Everyday  Health
Many Women With Breast Cancer Don't Need High Dose Tamoxifen | Everyday Health

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local  and Contralateral Recurrence in Breast Intraepithelial Neoplasia | Journal  of Clinical Oncology
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia | Journal of Clinical Oncology

Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in  physiology in mice | eLife
Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice | eLife

Low Dose Tamoxifen for Risk Reduction - Dr Deanna Attai
Low Dose Tamoxifen for Risk Reduction - Dr Deanna Attai

Initiation and tolerance of chemoprevention among women with high-risk  breast lesions: the potential of low-dose tamoxifen | SpringerLink
Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen | SpringerLink

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized  Controlled Trial | Journal of Clinical Oncology
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial | Journal of Clinical Oncology

Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast  Noninvasive Disease
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease

Frontiers | Tamoxifen Twists Again: On and Off-Targets in Macrophages and  Infections
Frontiers | Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections

Low-dose tamoxifen in the treatment of breast ductal intraepithelial  neoplasia: results of a large observational study - Annals of Oncology
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study - Annals of Oncology

Relevance of breast cancer hormone receptors and other factors to the  efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised  trials - The Lancet
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials - The Lancet

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local  and Contralateral Recurrence in Breast Intraepithelial Neoplasia | Journal  of Clinical Oncology
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia | Journal of Clinical Oncology

Frontiers | Integrated Data Analysis of Six Clinical Studies Points Toward  Model-Informed Precision Dosing of Tamoxifen
Frontiers | Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen

Barriers to preventive therapy for breast and other major cancers and  strategies to improve uptake - ecancer
Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake - ecancer

Impact of short-term low-dose tamoxifen on molecular breast imaging  background parenchymal uptake: a pilot study | Breast Cancer Research |  Full Text
Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study | Breast Cancer Research | Full Text

Progress in preventive therapy for cancer: a reminiscence and personal  viewpoint | British Journal of Cancer
Progress in preventive therapy for cancer: a reminiscence and personal viewpoint | British Journal of Cancer

Tamoxifen: what you should and shouldn't avoid - OWise UK
Tamoxifen: what you should and shouldn't avoid - OWise UK

SABCS 2018: Low-dose tamoxifen was safe and effective at reducing  recurrence and new breast disease for patients with DCIS, LCIS, and ADH -  ecancer
SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients with DCIS, LCIS, and ADH - ecancer